Champions Oncology, Inc. (CSBR)
4.99
+0.03
(+0.60%)
USD |
NASDAQ |
Aug 24, 16:00
4.99
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology Shareholders Equity (Quarterly) : 3.939M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 3.939M |
| January 31, 2026 | 4.283M |
| October 31, 2025 | 4.17M |
| July 31, 2025 | 3.508M |
| April 30, 2025 | 3.772M |
| January 31, 2025 | 5.469M |
| October 31, 2024 | 0.681M |
| July 31, 2024 | -0.332M |
| April 30, 2024 | -1.903M |
| January 31, 2024 | -2.058M |
| October 31, 2023 | 0.093M |
| July 31, 2023 | 1.903M |
| April 30, 2023 | 4.636M |
| January 31, 2023 | 7.064M |
| October 31, 2022 | 9.172M |
| July 31, 2022 | 8.983M |
| April 30, 2022 | 9.096M |
| January 31, 2022 | 9.236M |
| October 31, 2021 | 8.071M |
| July 31, 2021 | 7.538M |
| April 30, 2021 | 7.428M |
| January 31, 2021 | 7.867M |
| October 31, 2020 | 6.893M |
| July 31, 2020 | 5.513M |
| April 30, 2020 | 5.099M |
| Date | Value |
|---|---|
| January 31, 2020 | 3.177M |
| October 31, 2019 | 2.114M |
| July 31, 2019 | 1.728M |
| April 30, 2019 | 2.238M |
| January 31, 2019 | 2.323M |
| October 31, 2018 | 1.992M |
| July 31, 2018 | 0.602M |
| April 30, 2018 | 0.003M |
| January 31, 2018 | 0.472M |
| October 31, 2017 | 0.373M |
| July 31, 2017 | 0.29M |
| April 30, 2017 | 0.40M |
| January 31, 2017 | 2.04M |
| October 31, 2016 | 3.205M |
| July 31, 2016 | 3.176M |
| April 30, 2016 | 0.238M |
| January 31, 2016 | 2.259M |
| October 31, 2015 | 4.102M |
| July 31, 2015 | 5.903M |
| April 30, 2015 | 8.059M |
| January 31, 2015 | -4.144M |
| October 31, 2014 | -1.858M |
| July 31, 2014 | 0.439M |
| April 30, 2014 | 3.197M |
| January 31, 2014 | 4.486M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 433.86M |
| Avantor, Inc. | 5.630B |
| Personalis, Inc. | 235.16M |
| Adaptive Biotechnologies Corp. | 142.91M |
| 10X Genomics, Inc. | 825.55M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.99M |
| Total Liabilities (Quarterly) | 22.92M |
| Debt to Equity Ratio | 1.167 |
| Current Ratio | 0.9647 |
| Net Debt Paydown Yield | 0.51% |